Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
This study has been completed.
Study NCT00002475 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: June 11, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Colorectal Cancer
Kidney Cancer
Lung Cancer
Malignant Mesothelioma
Pancreatic Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma, Renal Cell
Colorectal Neoplasms
Kidney Neoplasms
Lung Neoplasms
Mesothelioma
Pancreatic Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adenoma
Breast Diseases
Carcinoma
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Kidney Diseases
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Pancreatic Diseases
Rectal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Thoracic Neoplasms
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
allogeneic tumor cell vaccine
autologous tumor cell vaccine
recombinant interferon alfa
recombinant interferon gamma
sargramostim
cyclophosphamide
Additional drug interventions recognized in this trial
Interferon Alfa-2a
Interferon Type I, Recombinant
Interferon Type II
Interferon-alpha
Interferon-gamma, Recombinant
Interferons
More general drug interventions related to this trial
Alkylating Agents
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Antiviral Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
St. Vincent Medical Center - Los Angeles
Back to top of Main Content
